By analyzing thousands of genetic risk variants, a new algorithm developed by Columbia researchers may be able to predict your risk of developing chronic kidney disease decades before onset.
Using advanced imaging methods, researchers have gained insight into how a common target of drugs sends cellular signals, a finding that may lead to better and more precise therapeutics.
Twelve Columbia research teams have been awarded Columbia Life Science Accelerator pilot grants to develop technologies that aim to change the way patients are treated or diagnosed.
Even a brief exposure to addictive medications for surgery-related pain or anxiety can lead to long-term use, a study by Columbia researchers has found.
A new study from researchers at Columbia University is the first to quantitatively link psychological stress to graying hair in people and find that the process is reversible.
Three early-career scientists at VP&S—X. Shawn Liu (Physiology & Cellular Biophysics), Xuebing Wu (Medicine), and Nikhil Sharma (Molecular Pharmacology & Therapeutics)—are 2021 Paul Marks Scholars.
Spectacular images of a molecule that shuttles omega-3 fatty acids into the brain may open a doorway for delivering neurological therapeutics to the brain.
The new center builds on the school’s long-standing commitment to LGBTQ health and will study health among sexual and gender minority populations across the lifespan, with an emphasis on resilience.
The annual Vagelos Precision Medicine Pilot Grants have been awarded to five teams of VP&S researchers conducting innovative basic science, translational, and clinical research.
Programs that bring pharmacists into Black-owned barbershops could dramatically improve hypertension control and reduce heart disease disparities among Black men at a relatively modest cost.